Amidebio, LLC
Doing business as Amidebio LLC
At a glance
EmployeesNot reported
In business since2009
HeadquartersLouisville, CO
US patents6
SAM.gov UEIUN9KNR7J6J77
CAGE code5NBN2
Incorporated inCO
- peptide drug candidates
- in-silico design
- peptide synthesis capabilities
- peptides
- metabolic disease
- customers seeking high purity
- low cost solutions
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
6 US patents granted 2014–2021, 1 of them in the five years to SEP 2025.
Pharmaceuticals 3Biotechnology 2Measurement 1
- Glucagon analogs and methods of use thereofUS 11,179,444 · granted NOV 23, 2021
- Methods, compositions, diagnostics and assays for the treatment of Alzheimer's diseaseUS 10,233,222 · granted MAR 19, 2019
- Efficient production of peptidesUS 9,266,934 · granted FEB 23, 2016
- Chemically and thermodynamically stable insulin analogues and improved methods for their productionUS 9,163,073 · granted OCT 20, 2015
- Chemically and thermodynamically stable insulin analogues and improved methods for their productionUS 9,006,176 · granted APR 14, 2015
Newest 5 shown · Granted to AmideBio, LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Amidebio, LLC | Louisville | CO | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.